Value of a newly sequenced bacterial genome

Area of Science:

• Genomics
• Microbiology
• Bioinformatics

Background:

• Next-generation sequencing (NGS) has democratized high-throughput sequencing, generating large volumes of bacterial genomic data.
• This surge in data has raised expectations for accelerating antibacterial discovery and vaccine development.
• However, the quality of deposited genomes, particularly draft genomes, poses challenges.

Purpose of the Study:

• To review the impact of newly sequenced bacterial genomes on antibacterial discovery and vaccinology.
• To discuss factors contributing to the rise of draft genome deposits.
• To highlight the loss of biological information associated with incomplete genome sequencing.

Main Methods:

• Literature review of studies on next-generation sequencing applications in bacterial genomics.
• Analysis of trends in public genome databases regarding draft genome submissions.
• Discussion of the implications of draft genomes for drug and vaccine target identification.

Main Results:

• While NGS has identified numerous potential drug and vaccine targets, success rates in genome-based analysis remain suboptimal.
• There is a significant increase in draft genome deposits, often due to limited further interest in specific bacterial genomes.
• Incomplete sequencing and annotation of draft genomes lead to the loss of valuable biological information.

Conclusions:

• The widespread use of NGS has led to an increase in draft bacterial genomes, potentially limiting their utility for antibacterial discovery and vaccine development.
• Assessing the scientific value of newly sequenced genomes, especially draft versions, is crucial.
• Addressing the factors contributing to draft genome proliferation is necessary to maximize the benefits of genomic data.